Enzastaurin Versus Lomustine in Glioblastoma

This study has been completed.
Sponsor:
Information provided by (Responsible Party):
Eli Lilly and Company
ClinicalTrials.gov Identifier:
NCT00295815
First received: February 22, 2006
Last updated: June 12, 2014
Last verified: June 2014
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: May 2014
  Primary Completion Date: August 2007 (Final data collection date for primary outcome measure)